Form 4: GE HealthCare Technologies Inc. Executive Kevin Michael O'Neill Reports Stock Transaction
SEC Form 4 Filing
Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 3, 2024, Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., had 1,533 shares of common stock withheld to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share was $83.44.
- Following the transaction, O'Neill directly owns 22,477 shares of GE HealthCare Technologies Inc. common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations on vested stock, so it's neutral in sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which investors monitor for signals about a company's prospects.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard procedure for covering tax obligations on vested equity.
Key Dates
| Date | Description |
|---|---|
| 08/03/2024 | Date of stock transaction (withholding of shares for tax obligations). |
| 08/06/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.